TherapeuticsMD (TXMD) Profit After Tax (2010 - 2026)
TherapeuticsMD (TXMD) posted Profit After Tax of $95000.0 for Q1 2026, up 117.99% on a QoQ basis from -$528000.0 in Q4 2025, and up 114.55% year-over-year from $44279.1 in Q1 2025.
TherapeuticsMD (TXMD) Profit After Tax (2010 - 2026) Analysis & Trends
TherapeuticsMD's Profit After Tax history runs 17 years deep, the most recent figure standing at $95000.0 for Q1 2026.
- Quarterly Profit After Tax rose 114.55% year-over-year to $95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168000.0 (up 107.67% YoY) and the FY2025 annual result came in at -$569000.0, up 75.39% from the prior year.
- Profit After Tax was $95000.0 for Q1 2026 at TherapeuticsMD, up from -$528000.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $159.4 million in Q4 2022 and bottomed at -$49.0 million in Q1 2022.
- A 5-year average of $11.5 million and a median of -$653000.0 in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax jumped 470.99% — and 2025, when it plunged 536.36%.
- TherapeuticsMD's Profit After Tax stood at $159.4 million in 2022, then tumbled by 100.55% to -$883000.0 in 2023, then jumped by 113.7% to $121000.0 in 2024, then plunged by 536.36% to -$528000.0 in 2025, then jumped by 117.99% to $95000.0 in 2026.
- Business Quant data shows TXMD's Profit After Tax at $95000.0 in Q1 2026, -$528000.0 in Q4 2025, and $50000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | -528,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 551,000.00 |
| Mar 31, 2025 | -653,000.00 |
| Dec 31, 2024 | 121,000.00 |
| Sep 30, 2024 | -567,000.00 |
| Jun 30, 2024 | -1.09 Mn |
| Mar 31, 2024 | -734,000.00 |
| Dec 31, 2023 | -883,000.00 |
| Sep 30, 2023 | -3.38 Mn |
| Jun 30, 2023 | -2.41 Mn |
| Mar 31, 2023 | -3.60 Mn |
| Dec 31, 2022 | 159.38 Mn |
| Sep 30, 2022 | -14.63 Mn |
| Jun 30, 2022 | 112.28 Mn |
| Mar 31, 2022 | -49.02 Mn |
| Dec 31, 2021 | -42.96 Mn |
| Sep 30, 2021 | -47.42 Mn |
| Jun 30, 2021 | -42.65 Mn |